TR200002675T2 - Paroksetinin kristalin formu. - Google Patents

Paroksetinin kristalin formu.

Info

Publication number
TR200002675T2
TR200002675T2 TR2000/02675T TR200002675T TR200002675T2 TR 200002675 T2 TR200002675 T2 TR 200002675T2 TR 2000/02675 T TR2000/02675 T TR 2000/02675T TR 200002675 T TR200002675 T TR 200002675T TR 200002675 T2 TR200002675 T2 TR 200002675T2
Authority
TR
Turkey
Prior art keywords
paroxetine
crystalline form
free
depression
pure
Prior art date
Application number
TR2000/02675T
Other languages
English (en)
Turkish (tr)
Inventor
Simon Craig Andrew
Ward Neal
Mcilwaine Wilson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9805581.7A external-priority patent/GB9805581D0/en
Priority claimed from GBGB9813054.5A external-priority patent/GB9813054D0/en
Priority claimed from GBGB9817115.0A external-priority patent/GB9817115D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of TR200002675T2 publication Critical patent/TR200002675T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR2000/02675T 1998-03-16 1999-03-16 Paroksetinin kristalin formu. TR200002675T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9805581.7A GB9805581D0 (en) 1998-03-16 1998-03-16 Novel compounds
GBGB9813054.5A GB9813054D0 (en) 1998-06-17 1998-06-17 Novel compounds
GBGB9817115.0A GB9817115D0 (en) 1998-08-06 1998-08-06 Novel compounds

Publications (1)

Publication Number Publication Date
TR200002675T2 true TR200002675T2 (tr) 2000-12-21

Family

ID=27269245

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02675T TR200002675T2 (tr) 1998-03-16 1999-03-16 Paroksetinin kristalin formu.

Country Status (18)

Country Link
EP (1) EP1064282A1 (no)
JP (1) JP2002506865A (no)
KR (1) KR20010041947A (no)
CN (1) CN1300286A (no)
AP (1) AP2000001907A0 (no)
AU (1) AU2847199A (no)
BG (1) BG104839A (no)
BR (1) BR9908825A (no)
CA (1) CA2323896A1 (no)
EA (1) EA200000946A1 (no)
HU (1) HUP0101215A3 (no)
ID (1) ID27596A (no)
IL (1) IL138390A0 (no)
NO (1) NO20004583L (no)
PL (1) PL342931A1 (no)
SK (1) SK13622000A3 (no)
TR (1) TR200002675T2 (no)
WO (1) WO1999047519A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie

Also Published As

Publication number Publication date
BG104839A (en) 2001-09-28
JP2002506865A (ja) 2002-03-05
PL342931A1 (en) 2001-07-16
ID27596A (id) 2001-04-12
NO20004583D0 (no) 2000-09-14
NO20004583L (no) 2000-09-15
HUP0101215A3 (en) 2002-05-28
EP1064282A1 (en) 2001-01-03
CN1300286A (zh) 2001-06-20
BR9908825A (pt) 2000-11-21
CA2323896A1 (en) 1999-09-23
WO1999047519A1 (en) 1999-09-23
HUP0101215A2 (hu) 2002-04-29
IL138390A0 (en) 2001-10-31
EA200000946A1 (ru) 2001-02-26
AU2847199A (en) 1999-10-11
KR20010041947A (ko) 2001-05-25
SK13622000A3 (sk) 2001-03-12
AP2000001907A0 (en) 2000-09-30

Similar Documents

Publication Publication Date Title
UY34152A (es) ?oxazolidinonas substituidas y su uso?.
DE60010098D1 (de) 28-epirapaloge
TR200102029T2 (tr) 1-Heterosiklil ikameli diarilaminler.
DK0882021T3 (da) Nye phenanthridiner
TR200103574T2 (tr) Amid ikameli/katkılı imidazokinolinler
BR0215405A (pt) Composições e processos de uso de collajolie
ATE246678T1 (de) Zyclische amidino mittel als stickstoffoxid- synthase inhibitoren
DE60019100D1 (de) Im wesentlichen ölfreie cyclosporin zusammensetzungen
ATE196628T1 (de) Hydroxyamidinderivate verwendbar als stickoxidsynthese inhibitoren
NO20031860L (no) Kahalalid F
SE9802937D0 (sv) Novel compounds
NO964238D0 (no) Halofantrin-fri-base for behandling av malaria og blandinger
SE0003476D0 (sv) Compounds
FR2825273B1 (fr) Composition pour le traitement des signes cutanes du vieillissement
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
PT1204659E (pt) Benzofuranos serotoninergicos
GB2324091B (en) Metalloproteinase inhibitors
TR200002675T2 (tr) Paroksetinin kristalin formu.
TR200100133T2 (tr) FKBP İnhibitörleri
DK1244643T3 (da) Tryptaseinhibitorer
ATE268322T1 (de) Inhibitoren der tryptase
SE0100374D0 (sv) Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof
NO20021429D0 (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
DE50211461D1 (de) Pharmazeutische zusammensetzung enthaltend bulbophyllum
ATE227571T1 (de) Thrombin inhibitoren